Showing 1 - 2 results of 2 for search 'Marek Ancukiewicz', query time: 0.02s Refine Results
  1. 1
    P1134: BISPECIFIC ANTI-CD20/19 CAR-T – ZAMTOCABTAGENE AUTOLEUCEL FOR RELAPSED/REFRACTORY DLBCL – INTERIM ANALYSIS RESULTS OF DALY-II-USA STUDY

    P1134: BISPECIFIC ANTI-CD20/19 CAR-T – ZAMTOCABTAGENE AUTOLEUCEL FOR RELAPSED/REFRACTORY DLBCL – INTERIM ANALYSIS RESULTS OF DALY-II-USA STUDY by Nirav Shah, Richard Maziarz, Caron Jacobson, Iris Isufi, Monalisa Ghosh, Matthew Ulrickson, Miguel-Angel Perales, Matthew Lunning, Nancy Hardy, Anna Wijatyk, Marek Ancukiewicz, Madhavi Nallewar, Kimberly Coleman, Bethany Prudner, Esther Eromosele, Remigiusz Kaleta, David Miklos

    Published 2023-08-01
    Get full text
    Article
  2. 2
    Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancer.

    Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancer. by Jeffrey A Meyerhardt, Marek Ancukiewicz, Thomas A Abrams, Deborah Schrag, Peter C Enzinger, Jennifer A Chan, Matthew H Kulke, Brian M Wolpin, Michael Goldstein, Lawrence Blaszkowsky, Andrew X Zhu, Meaghan Elliott, Eileen Regan, Rakesh K Jain, Dan G Duda

    Published 2012-01-01
    Get full text
    Article

Search Tools: